NCT05761379

Clinical Study of Light Therapy to Control Myopia Progression in Children

Clinical Study of Low Lever Red Light Therapy With 650nm to Control Myopia Progression in Children

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 83 (estimated)
• Sponsor: Beijing Airdoc Technology Co., Ltd. · Industry
• Sex: All
• Age: 6 Years – 16 Years
• Healthy volunteers: Accepted

Summary

Low-lever red light therapy (LLLT) has been used to control myopia progression in China for a few years besides amblyopia therapy for a few decades. This study is to test the efficacy of PBM therapy to myopia children as well as to compare two types of PBM therapy to control myopia progression within one month.

Detailed description

LLLT utilized the 650-nm red light to provide sufficient energy to stimulate the tissue without causing damage to the surrounding tissues. And several researchers reported the long-term efficacy of LLLT in slowing the progression of myopia to date. These studies were reported various illumination and irradiance. This study is to test the efficacy of LLLT comparing to the control group as well as to test whether two types of lighting design will be different to the efficacy and safety.

Conditions

• Myopia, Progressive

Interventions

Type	Name	Description
DEVICE	Photobiomodualtion Therapy	low lever light therapy with laser semi-conductor at wavelength of 650nm
DEVICE	Single vision spectacles for correction myopia	Provide the distance best corrected vision acuity of refractive error of myopia for all the groups

Timeline

• Start date: 2023-03-28
• Primary completion: 2024-06-30
• Completion: 2024-12-30
• First posted: 2023-03-09
• Last updated: 2023-08-01

Locations

1 site across 1 country: China